Evolent Health
EVH
118 hedge funds and large institutions have $435M invested in Evolent Health in 2016 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 23 reducing their positions, and 19 closing their positions.
495% more call options, than puts
Call options by funds: $2.16M | Put options by funds: $363K
130% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 23
53% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 19
7% more funds holding
Funds holding: 110 → 118 (+8)
3.28% less ownership
Funds ownership: 59.24% → 55.96% (-3.3%)
35% less capital invested
Capital invested by funds: $672M → $435M (-$236M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
Top Sellers
EVH Hedge Fund Activity: Q4 2016 in Review
118 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q4 2016, worth a combined $435M — down 35% from $672M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new EVH positions and 19 closed out — a net gain of 10 holders — while 53 added to existing stakes and 23 trimmed.
The largest buyer was William Blair & Company, adding an estimated $17.8M. The largest seller was Capital World Investors, exiting entirely with an estimated $33.7M sold.
- 118 institutional investors held Evolent Health (EVH) as of Q4 2016, up from 110 in Q3 2016.
- Funds reported $435M of Evolent Health stock for Q4 2016, down 35% quarter-over-quarter.
- 29 funds opened new Evolent Health positions in Q4 2016 and 19 closed out, a net change of +10 holders.
- The largest Evolent Health buyer in Q4 2016 was William Blair & Company, an estimated $17.8M added.
- The largest Evolent Health seller in Q4 2016 was Capital World Investors, an estimated $33.7M sold.
Based on aggregated 13F filings for Q4 2016.